Pfizer Ends Sangamo Alliance With Gene Therapy for Hemophilia on Cusp of FDA Filing
Posted:
Pfizer is walking away from partner Sangamo Therapeutics ahead of expected regulatory submissions for the hemophilia A gene therapy they co-developed. Cash-strapped Sangamo said it is now looking for a new partner for the program.
Read the full article in the latest MedCity News blog post here.
A major workforce optimisation programme has started at the Countess of Chester Hospital NHS Foundation Trust in partnership with workforce planning specialists, SARD.
Read more here.
Nursing education is really no longer limited to textbooks and clinical rotations. The accelerated embrace of digital technologies is transforming the way future nurses learn, with education becoming more accessible, flexible and interactive. Technology, ranging from AI-powered tutoring systems to…
Attendees
Sponsors and
Exhibitors
AI Training
for Doctors Workshops
Contact us